Drug class
Ammonia-scavenging nitrogen-binding agent; treatment for urea-cycle disorders
Mechanism of action
Phenylbutyrate is metabolised to phenylacetate, which conjugates with glutamine to form phenylacetylglutamine. This nitrogen-containing conjugate is excreted in urine, providing an alternative pathway for waste-nitrogen removal and lowering plasma ammonia.
General use cases
- Adjunctive chronic management of patients with urea-cycle disorders involving deficiencies of carbamoyl phosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase, in conjunction with dietary management and other indicated therapy.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
